Vitamin Shoppe (VSI) Misses Q3 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts VSI Hot Sheet
Join SI Premium – FREE
Vitamin Shoppe (NYSE: VSI) reported Q3 EPS of $0.03, $0.14 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $288.2 million versus the consensus estimate of $298.11 million. Management also reported total comp sales down 6.6%-5.8 excluding hurricane impacts.
For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corpay, Inc. (CPAY) Tops Q3 EPS by 35c; offers guidance
- e.l.f. Beauty, Inc. (ELF) Tops Q2 EPS by 64c, Beats on Revenue; Offers FY27 Guidance
- McKesson (MCK) Tops Q2 EPS by 97c; raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
